A detailed history of Dn B Asset Management As transactions in Royalty Pharma PLC stock. As of the latest transaction made, Dn B Asset Management As holds 67,454 shares of RPRX stock, worth $2.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,454
Previous 71,106 5.14%
Holding current value
$2.25 Million
Previous $1.81 Million 15.77%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$25.75 - $33.86 $94,039 - $123,656
-3,652 Reduced 5.14%
67,454 $2.1 Million
Q4 2024

Feb 12, 2025

BUY
$24.28 - $28.39 $73,641 - $86,106
3,033 Added 4.46%
71,106 $1.81 Million
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $1.74 Million - $1.99 Million
68,073 New
68,073 $1.93 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $14.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.